Skip to main content
. 2015 May 7;10(5):e0125343. doi: 10.1371/journal.pone.0125343

Fig 4. JARID1B-silencing suppresses tumorsphere formation and increases cisplatin sensitivity.

Fig 4

(A) Tumorspheres generated from wild type and JARID1B-shRNA 1- and 2- infected SK-N-BE(2) cells. (B and C) JARID1B knockdown caused significant reduction in number and sizes of tumorspheres formed. (D) Cell viability assay show that the cytotoxicity effect of cisplatin was significantly enhanced by JARID1B silencing. All assays were repeated at least three times. * and ** indicate p<0.05 and p<0.001.